Multiple antibiotic resistance in Stenotrophomonas maltophilia

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1140-1142

  Alonso, Ana ^a   Martínez, José L ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CHLORAMPHENICOL; CIPROFLOXACIN; IMIPENEM; NALIDIXIC ACID; NORFLOXACIN; OUTER MEMBRANE PROTEIN; QUINOLONE; TETRACYCLINE; TIMENTIN;

ARTICLE; BACTERIUM ISOLATION; BACTERIUM MUTANT; DRUG TRANSPORT; GENE EXPRESSION; HOSPITAL INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; STENOTROPHOMONAS MALTOPHILIA;

EID: 0343683417     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1140     Document Type: Article

References (28)

1. Arpi, M., M. A. Victor, J. K. Moller, V. Jonsson, M. M. Hansen, N. A. Peterslund, and B. Bruun. 1994. Changing etiology of bacteremia in patients with hematological malignancies in Denmark. Scand. J. Infect. Dis. 26:157-162.
2. Bergogne Berezin, E., D. Decre, and M. L. Joly Guillou. 1993. Opportunistic nosocomial multiply resistant bacterial infections: their treatment and prevention. J. Antimicrob. Chemother. 32(Suppl. A):39-47.
3. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
4. Denton, M., N. J. Todd, and J. M. Littlewood. 1996. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients. Eur. J. Clin. Microbiol. Infect. Dis. 15:402-405.
5. Fukuoka, T., N. Masuda, T. Takenouchi, N. Sekine, M. Iijima, and S. Ohya. 1991. Increase in susceptibility of Pseudomonas aeruginosa to carbapenem antibiotics in low-amino-acid media. Antimicrob. Agents Chemother. 35: 529-532.
6. George, A. M. 1996. Multidrug resistance in enteric and other gram-negative bacteria. FEMS Microbiol. Lett. 139:1-10.
7. Goldman, J. D., D. G. White, and S. B. Levy. 1996. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob. Agents Chemother. 40:1266-1269.
8. Hamzehpour, M. M., J. C. Pechere, P. Plesiat, and T. Kohler. 1995. OprK and OprM define two genetically distinct multidrug efflux systems in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39:2392-2396.
9. Heath, T., and B. Currie. 1995. Nosocomial and community-acquired Xanthomonas maltophilia infection in tropical Australia. J. Hosp. Infect. 30:309-313.
10. Karpati, F., A. S. Malmborg, H. Alfredsson, L. Hjelte, and B. Strandvik. 1994. Bacterial colonisation with Xanthomonas maltophilia: a retrospective study in a cystic fibrosis patient population. Infection 22:258-263.
11. Lecso Bornet, M., J. Pierre, D. Sarkis Karam, S. Lubera, and E. Bergogne Berezin. 1992. Susceptibility of Xanthomonas maltophilia to six quinolones and study of outer membrane proteins in resistant mutants selected in vitro. Antimicrob. Agents Chemother. 36:669-671.
12. Lewis, K. 1994. Multidrug resistance pumps in bacteria: variations on a theme. Trends Biochem. Sci. 19:119-123.
13. Li, X. Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline. chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741.
14. Lomovskaya, O., K. Lewis, and A. Matin. 1995. EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB. J. Bacteriol. 177:2328-2334.
15. Ma, D., D. N. Cook, J. E. Hearst, and H. Nikaido. 1994. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 2:489-193.
16. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
17. Maningo, E., and C. Watanakunakorn. 1995. Xanthomonas maltophilia and Pseudomonas cepacia in lower respiratory tracts of patients in critical care units. J. Infect. 31:89-92.
18. Neu, H. C. 1992. Quinolone antimicrobial agents. Annu. Rev. Med. 43:465-486.
19. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
20. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
21. Paton, R., R. S. Miles, and S. G. Amyes. 1994. Biochemical property of inducible beta-lactamases produced from Xanthomonas maltophilia. Antimicrob. Agents Chemother. 38:2143-2149.
22. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
23. Seoane, A. S., and S. B. Levy. 1995. Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli. J. Bacteriol. 177:3414-3419.
24. Smit, W. J., A. L. Boquest, J. E. Geddes, and F. A. Tosolini. 1994. The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management. Pathology 26:321-324.
25. Vartivarian, S., E. Anaissie, G. Bodey, H. Sprigg, and K. Rolston. 1994. A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob. Agents Chemother. 38: 624-627.
26. Vartivarian, S. E., K. A. Papadakis, and E. J. Anaissie. 1996. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch. Intern. Med. 156:433-435.
27. Wilcox, M. H., T. G. Winstanley, and R. C. Spencer. 1994. Outer membrane protein profiles at Xanthomonas maltophilia isolates displaying temperature dependent susceptibility to gentamicin. J. Antimicrob. Chemother. 33:663-666.
28. Yao, J. D., M. Louie, L. Louie, J. Goodfellow, and A. E. Simor. 1995. Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia. J. Clin. Microbiol. 33: 1428-1430.